Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)
About the company
Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA.
Stock price
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
Revenues - Income - Cash Flows (in USD Million)
Margins (in %)
Return on capital (in %)
Ratios (in %)
Industry margins
Industry workforces
Industry revenues and market cap
Industry ratios
90-days Stock Price Forecast (in %)
Industry peers
| Name | Ticker | Market capitalization (in USD Million) | Revenues (in USD Million) | Price/Book | Price/Earning | Net margin (in %) |
|---|---|---|---|---|---|---|
| Horizon Therapeutics Plc | HZNP | 11600.40 | 1376.00 | 4.95 | 18.29 | 43.06 |
| Catalent, Inc. | CTLT | 10932.13 | 2872.00 | 5.49 | 104.81 | 3.63 |
| Perrigo Co. Plc | PRGO | 7561.03 | 4837.00 | 1.30 | 51.58 | 3.02 |
| Bausch Health Cos., Inc. | BHC | 6512.14 | 8597.00 | 9.09 | -3.44 | -21.96 |
| Jazz Pharmaceuticals Plc | JAZZ | 6255.75 | 2188.00 | 2.16 | 22.86 | 12.81 |
| United Therapeutics Corp. | UTHR | 5188.38 | 1443.00 | 1.80 | 10.01 | 36.59 |
| MyoKardia, Inc. | MYOK | 4329.06 | 34.00 | 12.58 | -13.96 | -201.73 |
| Axsome Therapeutics, Inc. | AXSM | 2672.60 | None | 18.14 | -29.71 | None |
| ArQule, Inc. | ARQL | 2240.00 | 5.00 | 15.75 | -55.56 | -808.06 |
| Pacira Biosciences, Inc. | PCRX | 2231.88 | 435.00 | 5.98 | -5314.00 | -0.02 |
| SAGE Therapeutics, Inc. | SAGE | 2162.16 | 9.00 | 2.54 | -3.34 | -413.06 |
| Corcept Therapeutics, Inc. | CORT | 2095.96 | 335.00 | 4.81 | 19.75 | 31.64 |
| Revolution Medicines, Inc. | RVMD | 1920.45 | 48.00 | 4.98 | -27.12 | -146.29 |
| Prestige Consumer Healthcare, Inc. | PBH | 1844.67 | 963.00 | 1.55 | 13.01 | 14.77 |
| Madrigal Pharmaceuticals, Inc. | MDGL | 1673.70 | 0.00 | 4.47 | -16.38 | -624.74 |
| Ironwood Pharmaceuticals, Inc. | IRWD | 1601.40 | 440.00 | -22.67 | 18.89 | 19.14 |
| Innoviva, Inc. | INVA | 1574.09 | 285.00 | 3.72 | 8.15 | 66.41 |
| Intercept Pharmaceuticals, Inc. | ICPT | 1506.88 | 272.00 | -44.85 | -4.39 | -127.53 |
| Portola Pharmaceuticals, Inc. | PTLA | 1329.78 | 121.00 | 19.53 | -4.77 | -232.73 |
| Zogenix, Inc. | ZGNX | 1313.55 | 5.00 | 3.59 | -3.09 | -241.62 |
| Supernus Pharmaceuticals, Inc. | SUPN | 1254.96 | 402.00 | 1.99 | 10.76 | 28.90 |
| Theravance Biopharma, Inc. | TBPH | 1196.43 | 88.00 | -8.40 | -4.85 | -280.80 |
| Revance Therapeutics, Inc. | RVNC | 1181.11 | 0.00 | 4.66 | -6.33 | 41.82 |
| Amphastar Pharmaceuticals, Inc. | AMPH | 1088.78 | 327.00 | 2.72 | 21.37 | 15.90 |
| Endo International Plc | ENDP | 800.28 | 3014.00 | -1.09 | -2.85 | -9.09 |
| BellRing Brands, Inc. | BRBR | 764.79 | 954.00 | -0.41 | 5.80 | 13.98 |
| Eagle Pharmaceuticals, Inc. | EGRX | 684.60 | 192.00 | 3.68 | 271.67 | 1.29 |
| Aerie Pharmaceuticals, Inc. | AERI | 678.96 | 79.00 | 5.39 | -3.35 | -252.92 |
| Assembly Biosciences, Inc. | ASMB | 672.22 | 16.00 | 3.01 | -6.76 | -601.75 |
| Collegium Pharmaceutical, Inc. | COLL | 590.58 | 299.00 | 4.23 | -45.71 | -4.21 |
| Anika Therapeutics, Inc. | ANIK | 537.18 | 125.00 | 1.86 | 19.38 | 22.73 |
| Catalyst Pharmaceuticals, Inc. | CPRX | 487.92 | 119.00 | 4.75 | 11.12 | 36.09 |
| Intersect ENT, Inc. | XENT | 411.20 | 102.00 | 3.88 | -8.24 | -48.61 |
| BioDelivery Sciences International, Inc. | BDSI | 408.48 | 130.00 | 5.84 | -55.50 | -5.01 |
| ANI Pharmaceuticals, Inc. | ANIP | 378.36 | 203.00 | 1.93 | -242.54 | -0.67 |
| MEI Pharma, Inc. | MEIP | 354.41 | 5.00 | 6.10 | -9.09 | -539.48 |
| Albireo Pharma, Inc. | ALBO | 343.07 | 11.00 | 3.49 | -4.49 | -730.55 |
| Mallinckrodt Plc | MNK | 233.52 | 3037.00 | 0.12 | -0.19 | -39.56 |
| Marinus Pharmaceuticals, Inc. | MRNS | 168.21 | 0.00 | 6.51 | -2.50 | None |
| Agile Therapeutics, Inc. | AGRX | 166.97 | None | 2.72 | -8.09 | None |
| Zynerba Pharmaceuticals, Inc. | ZYNE | 144.90 | 0.00 | 2.38 | -4.04 | -699.94 |
| Cerecor, Inc. | CERC | 117.76 | 7.00 | 7.53 | -5.22 | -429.22 |
| Ampio Pharmaceuticals, Inc. | AMPE | 97.81 | 1.00 | 68.40 | -5.26 | None |
| AcelRx Pharmaceuticals, Inc. | ACRX | 94.40 | 2.00 | -1.74 | -1.69 | -644.25 |
| Evoke Pharma, Inc. | EVOK | 84.96 | None | 29.50 | -12.64 | None |
| Adamas Pharmaceuticals, Inc. | ADMS | 71.68 | 57.00 | -4.57 | -0.77 | -160.44 |
| CTI BioPharma Corp. | CTIC | 67.85 | 3.00 | 3.03 | -1.64 | -111.83 |
| Aclaris Therapeutics, Inc. | ACRS | 67.65 | 4.00 | 1.19 | -0.49 | None |
| Oramed Pharmaceuticals, Inc. | ORMP | 63.36 | 3.00 | 5.10 | -4.96 | -464.15 |
| Cassava Sciences, Inc. | SAVA | 56.81 | 41.00 | 2.99 | -12.46 | 76.71 |
| SCYNEXIS, Inc. | SCYX | 48.89 | 0.00 | 10.27 | -1.26 | -30.84 |
| Cumberland Pharmaceuticals, Inc. | CPIX | 48.60 | 47.00 | 0.99 | -10.80 | -9.59 |
| Natural Alternatives International, Inc. | NAII | 48.37 | 114.00 | 0.66 | -12.80 | -3.19 |
| IsoRay, Inc. | ISR | 37.52 | 9.00 | 7.00 | -11.20 | -36.08 |
| Lipocine, Inc. | LPCN | 36.90 | 0.00 | 8.79 | -2.46 | None |
| Acasti Pharma, Inc. | ACST | 35.84 | 827.00 | 2.33 | -0.58 | -7.45 |
| Neos Therapeutics, Inc. | NEOS | 34.50 | 65.00 | -2.65 | -1.97 | -26.74 |
| PLx Pharma, Inc. | PLXP | 27.99 | 0.00 | -2.68 | -2.96 | 119.04 |
| CytRx Corp. | CYTR | 22.11 | 0.00 | 1.60 | -3.19 | 408.46 |
| EyeGate Pharmaceuticals, Inc. | EYEG | 19.61 | 3.00 | 2.44 | -1.66 | -264.21 |
| Regulus Therapeutics, Inc. | RGLS | 14.91 | 0.00 | 1.31 | -0.70 | -272.13 |
| Tetraphase Pharmaceuticals, Inc. | TTPH | 12.30 | 8.00 | 0.65 | -0.15 | -798.18 |
| Intec Pharma Ltd. | NTEC | 10.90 | None | 1.40 | -0.25 | None |
| VIVUS, Inc. | VVUS | 8.69 | 73.00 | -0.19 | -0.29 | -39.28 |
| Sonoma Pharmaceuticals, Inc. | SNOA | 6.74 | 19.00 | 1.07 | -2.16 | -25.58 |
| KemPharm, Inc. | KMPH | 6.02 | 15.00 | -0.17 | -0.35 | -120.48 |
| Hepion Pharmaceuticals, Inc. | HEPA | 5.68 | None | 1.77 | -0.48 | None |
| Tonix Pharmaceuticals Holding Corp. | TNXP | 4.36 | None | 1.09 | -0.09 | None |
| Ritter Pharmaceuticals, Inc. | RTTR | 0.45 | None | 0.17 | -0.03 | None |
Latest insider transactions
| Date | Role | Name | Transaction | Quantity | Quantity Owned After |
|---|
State Street Corp Purchases 23,005 Shares of Adamas Pharmaceuticals Inc (NASDAQ:ADMS)
State Street Corp increased its stake in Adamas Pharmaceuticals Inc (NASDAQ:ADMS) by 5.5% during the first quarter, according ...
Xeris Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
Xeris Pharmaceuticals reports positive topline data for insulin trial. Eloxx restarts cystic fibrosis study. Adamas Pharmaceuticals reports disappointing data f ...
Adamas Pharmaceuticals Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
BRIEF-Adamas Provides Program Update For ADS-5102 For Multiple Sclerosis Patients With Walking Impairment
ADAMAS PROVIDES PROGRAM UPDATE FOR ADS-5102 FOR MULTIPLE SCLEROSIS PATIENTS WITH WALKING IMPAIRMENT * ADAMAS PHARMACEUTICALS INC ...
After Market Hours: Eloxx Pharmaceuticals, ABM Industries Up; Hertz, Iveric, Adamas Pharm Tank
(RTTNews) - Eloxx Pharmaceuticals, Inc. (ELOX) - The clinical-stage biopharmaceutical company's shares surged nearly 50% on Wednesday after-hours trade. The company announced that enrollment in ...
ADMA Biologics Announces Martha J. Demski Elected to Board of Directors
ADMA Biologics, Inc. (NASDAQ:ADMA) ("ADMA"), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced ...